GENT.OL
Price:
$57.4
Market Cap:
$885.24M
Gentian Diagnostics ASA researches, develops, and produces biochemical reagents for use in medical diagnostics and research in Europe, Asia, and the United States. It offers in-vitro diagnostic reagents for clinical chemistry analyzers. The company's products include the gentian calprotectin immunoassay, a turbidimetric assay used for the measurement of calprotectin in plasma and serum for detection and assessment of inflammation; Cystatin C, a superior GFR marker for the diagnosis and therapeutic control of renal function; NT-proBNP Immunoassay for diagnosis, monitoring, and assessment of severity in individuals suspected of having congestive heart failure; and Canine c-reactive protein (CR...[Read more]
Industry
Medical - Devices
IPO Date
2016-12-14
Stock Exchange
OSL
Ticker
GENT.OL
According to Gentian Diagnostics ASA’s latest financial reports and current stock price. The company's current Current Ratio is 5.98. This represents a change of 4.46% compared to the average of 5.73 of the last 4 quarters.
The mean historical Current Ratio of Gentian Diagnostics ASA over the last ten years is 11.43. The current 5.98 Current Ratio has changed 5.14% with respect to the historical average. Over the past ten years (40 quarters), GENT.OL's Current Ratio was at its highest in in the June 2018 quarter at 28.44. The Current Ratio was at its lowest in in the March 2016 quarter at 0.
Average
11.43
Median
10.33
Minimum
5.38
Maximum
20.53
Discovering the peaks and valleys of Gentian Diagnostics ASA Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.62%
Maximum Annual Current Ratio = 20.53
Minimum Annual Increase = -38.82%
Minimum Annual Current Ratio = 5.38
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 5.38 | -3.89% |
| 2023 | 5.60 | -11.64% |
| 2022 | 6.33 | -14.60% |
| 2021 | 7.42 | -13.54% |
| 2020 | 8.58 | -29.00% |
| 2019 | 12.08 | -38.82% |
| 2018 | 19.75 | -3.78% |
| 2017 | 20.53 | 65.96% |
| 2016 | 12.37 | -23.73% |
| 2015 | 16.22 | 1.62% |
The current Current Ratio of Gentian Diagnostics ASA (GENT.OL) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
5.77
5-year avg
6.66
10-year avg
11.43
Gentian Diagnostics ASA’s Current Ratio is greater than Hofseth BioCare ASA (0.96), less than Nykode Therapeutics AS (170.98), greater than Navamedic ASA (1.49), greater than Lifecare AS (0.22), less than Lytix Biopharma AS (5.99), greater than ContextVision AB (publ) (4.95), less than Thor Medical ASA (8.87), greater than CodeLab Capital AS (-542.54), greater than Arctic Bioscience AS (0.83), greater than BerGenBio ASA (4.39),
| Company | Current Ratio | Market cap |
|---|---|---|
| 0.96 | $548.30M | |
| 170.98 | $737.99M | |
| 1.49 | $623.52M | |
| 0.22 | $77.67M | |
| 5.99 | $673.06M | |
| 4.95 | $324.94M | |
| 8.87 | $1.60B | |
| -542.54 | $36.28M | |
| 0.83 | $88.64M | |
| 4.39 | $45.74M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gentian Diagnostics ASA using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Gentian Diagnostics ASA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Gentian Diagnostics ASA's Current Ratio?
How is the Current Ratio calculated for Gentian Diagnostics ASA (GENT.OL)?
What is the highest Current Ratio for Gentian Diagnostics ASA (GENT.OL)?
What is the 3-year average Current Ratio for Gentian Diagnostics ASA (GENT.OL)?
What is the 5-year average Current Ratio for Gentian Diagnostics ASA (GENT.OL)?
How does the current Current Ratio for Gentian Diagnostics ASA (GENT.OL) compare to its historical average?